Results

eNauka >  Results >  Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Title: Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Authors: Siefker-Radtke, Arlene O; Lugowska, Iwona; Tupikowski, Krzysztof; Andric, Zoran G  ; Rezazadeh-Kalebasty, A; Curigliano, Giuseppe; Vaena, Daniel A; Vogl, FD; Currie, Graeme; Abella, S;
Kelly, William Kevin;
Issue Date: 2019
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 30 str. 365-365
WoS-ID: 000491295502344
URI: https://enauka.gov.rs/handle/123456789/811868
Project: Rainier Therapeutics, Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

10
WEB OF SCIENCETM

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.